Verition Fund Management
CVS icon

Verition Fund Management’s CVS Health CVS Stock Holding History

Verition Fund Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797K Buy
+7,700
New +$687K ﹤0.01% 1503
2025
Q1 		– Sell
-13,200
Closed -$593K – 3389
2024
Q4 		$593K Sell
13,200
-28,700
-68% -$1.61M ﹤0.01% 2372
2024
Q3 		$2.63M Buy
41,900
+27,000
+181% +$1.58M 0.01% 1252
2024
Q2 		$880K Buy
14,900
+1,100
+8% +$68.8K ﹤0.01% 1747
2024
Q1 		$1.1M Buy
13,800
+10,300
+294% +$787K 0.01% 1560
2023
Q4 		$276K Buy
+3,500
New +$249K ﹤0.01% 1845
2022
Q4 		– Sell
-10,800
Closed -$1.03M – 2260
2022
Q3 		$1.03M Buy
+10,800
New +$1.07M 0.01% 1373
2022
Q2 		– Sell
-36,300
Closed -$3.67M – 2484
2022
Q1 		$3.67M Buy
36,300
+20,400
+128% +$2.14M 0.04% 557
2021
Q4 		$1.64M Buy
+15,900
New +$1.47M 0.01% 1003

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Verition Fund Management's CVS Position: Q2 2026 in Review

Verition Fund Management reduced its CVS Health (CVS) stake by 28% in Q2 2026, selling an estimated $2.03M and leaving 57,993 shares worth $6M. The position accounts for 0.03% of the portfolio, ranked #576.

Verition Fund Management first reported a position in CVS in Q3 2013 and has held it in 42 quarters since. The position peaked at $22.7M in Q3 2023. 2,071 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Verition Fund Management held 57,993 shares of CVS Health worth $6M as of Q2 2026.
  • Verition Fund Management sold 22,767 CVS Health shares in Q2 2026, an estimated $2.03M.
  • CVS Health made up 0.03% of Verition Fund Management's portfolio in Q2 2026, its #576 holding.
  • Verition Fund Management first reported a position in CVS Health in Q3 2013 and has held it in 42 quarters since.
  • Verition Fund Management's CVS Health position peaked at $22.7M in Q3 2023.
  • 2,071 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.